Cargando…
NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments
Glioblastoma (GBM) is one of the most common and fatal malignancies worldwide, while its prognostic biomarkers are still being explored. This study aims to identify potential genes with clinical and prognostic significance by integrating bioinformatics analysis and investigating their function in HN...
Autores principales: | Wei, De, Shen, Shanghang, Lin, Kun, Lu, Feng, Zheng, Pengfeng, Wu, Shizhong, Kang, Dezhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990766/ https://www.ncbi.nlm.nih.gov/pubmed/33777094 http://dx.doi.org/10.3389/fgene.2021.611442 |
Ejemplares similares
-
Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and validation
por: Huang, Chaobin, et al.
Publicado: (2022) -
Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022) -
Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma
por: Liu, Ruifei, et al.
Publicado: (2022) -
Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments
por: Zhou, Jian, et al.
Publicado: (2021) -
Hypomethylation-induced prognostic marker zinc finger DHHC-type palmitoyltransferase 12 contributes to glioblastoma progression
por: Lu, Feng, et al.
Publicado: (2022)